Abstract
Transmission of Cryptosporidium can occur via contaminated food or water, contact with animals or other people. Exposures are often identified from outbreak investigations, but sources for sporadic disease and pathways to infection are still unclear. The aim of this review is to consolidate the literature to describe exposures associated with human cryptosporidiosis in industrialised countries.
Methods followed the recommendations made in the Cochrane Handbook for Systematic Reviews of Interventions. Three steps were used to identify the literature including electronic database searching using PubMed, Scopus and Web Of Science; reference list trawling; and an exploration of the grey literature. Quality was assessed using the Newcastle-Ottawa Scale. Screening of results was undertaken by two reviewers and data extracted using a standardised form. A narrative summary presented. Papers were included if they reported on sporadic cases and were published between 2008 and 2018. Exposures were grouped into pathways.
After full-text screening, eight articles (comprising 11 studies) were included, and seven (comprising 10 studies) were suitable for further synthesis. None of the identified grey literature was included. Four studies described case-control methods, two were case-case studies and one cross-sectional. Study year ranged from 1999 to 2017 and the studies were conducted in five, large countries in three continents: Europe (UK and the Netherlands), North America (USA, Canada), and Australia.
Included papers investigated water and animal exposures most frequently. Recreational water was not a major source of sporadic illness in this review. The person-to-person pathway represented the most consistent finding, with all three studies reporting on contact with a symptomatic individual demonstrating correlations between exposure and disease. This applied particularly to the home environment, which is increasingly understood to be a significant setting for spread of Cryptosporidium infection. Further work on this would help support public health messaging on preventing spread of disease at home.
Systematic review registration: PROSPERO number CRD42017056589.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=56589
Funding Statement
This research is jointly funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections (HPRU EZI) and the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Gastrointestinal Infections (HPRU GI) at the University of Liverpool in partnership with Public Health England/UK Health Security Agency (PHE/UKHSA), University of East Anglia, University of Oxford and the Institute of Food Research. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, PHE/UKHSA, or Public Health Wales.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
c.mckerr{at}liv.ac.uk
rachel.chalmers{at}wales.nhs.uk
roberto.vivancos{at}phe.gov.uk
sjobrien{at}liv.ac.uk
alison.waldram{at}phe.gov.uk
kevin.pollock.ic{at}uhi.ac.uk
robc{at}liv.ac.uk
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- AIDS
- Acquired Immunodeficiency Syndrome
- GRADE
- Grading of Recommendations, Assessments, Development and Evaluation
- HIV
- Human Immunodeficiency Virus
- NOS
- Newcastle-Ottawa Scale
- NIHR
- National Institute for Health Research Health Protection Research Unit
- OECD
- Organisation for Economic Co-operation and Development
- OR
- Odds Ratio
- PHE
- Public Health England
- PHW
- Public Health Wales
- PRISMA–P
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols
- ROBINS-I
- Risk of Bias In Non-randomized Studies - of Interventions
- RR
- Relative Risk/Risk Ratio
- UK
- United Kingdom
